| Financial Year |
March 31 2023 |
| Monetary Funds |
360,850,668.52 |
| Held-for-trading Financial Assets |
146,584,298.03 |
| Notes Receivable |
455,000.00 |
| Accounts Receivable |
284,719,395.71 |
| Advances to Suppliers |
34,690,588.11 |
| Other Receivables |
115,058,149.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
13,382,982.67 |
| Inventories |
399,510,400.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,463,758.05 |
| Total Current Assets |
1,445,840,029.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
913,638.89 |
| Long-term Equity Investment |
109,991,634.83 |
| Investment Properties |
29,853,127.62 |
| Fixed Assetes |
731,483,738.33 |
| Under-construction Projects |
80,480,165.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
101,299,899.48 |
| R&D expenses |
2,499,507.03 |
| Goodwill |
19,231,463.63 |
| Long-Term Deferred and Prepaid Expenses |
34,640,842.59 |
| Deferred Income Tax Assets |
37,615,702.56 |
| Other Non-Current Assets |
8,450,215.00 |
| Sub-Total of Non-Current Assets |
1,203,784,682.18 |
| Total Assets |
2,649,624,711.56 |
| Short-Term Loans |
230,396,666.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
13,564,987.52 |
| Accounts Payable |
214,395,542.57 |
| Accounts Received In Advance |
38,335.69 |
| Employee Compensation Payable |
14,155,164.34 |
| Taxes Payable |
17,807,373.97 |
| Interest Payable |
-- |
| Dividend Payable |
5,934,000.00 |
| Other payables |
58,847,666.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,219,743.30 |
| Other Current Liabilities |
9,474,060.85 |
| Sub-Total of Current Liabilities |
956,530,034.57 |
| Long-term Loans |
54,414,086.47 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,022,980.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,464,637.57 |
| Deferred Income Tax Liabilities |
4,681,008.96 |
| Other Non-Current Liabilities |
12,311,517.89 |
| Sub-Total of Non-Current Liabilities |
142,524,999.23 |
| Total Liabilities |
1,099,055,033.80 |
| Paid-In Capital(Or Share Stock) |
779,198,175.00 |
| Capital Surplus |
2,585,843,313.41 |
| Surplus Reserve |
33,579,171.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,962,585,982.23 |
| Minority Stockholder's Interest |
190,204,999.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,360,364,677.84 |
| Owner's Equity（Stockholder's Equity） |
1,550,569,677.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,649,624,711.56 |
